BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33566865)

  • 1. Hemodynamic determinants of left atrial strain in patients with hypertrophic cardiomyopathy: A combined echocardiography and CMR study.
    Tayal B; Malahfji M; Buergler JM; Shah DJ; Nagueh SF
    PLoS One; 2021; 16(2):e0245934. PubMed ID: 33566865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
    Yang Y; Yin G; Jiang Y; Song L; Zhao S; Lu M
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):1. PubMed ID: 31898543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance.
    Maragiannis D; Alvarez PA; Ghosn MG; Chin K; Hinojosa JJ; Buergler JM; Shah DJ; Nagueh SF
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):121-129. PubMed ID: 28748418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.
    Fujimoto K; Inoue K; Saito M; Higashi H; Kono T; Uetani T; Aono J; Nagai T; Nishimura K; Suzuki J; Okura T; Ikeda S; Nakatani S; Higaki J
    Echocardiography; 2018 Aug; 35(8):1138-1148. PubMed ID: 29648690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of left atrial strain analysis in adverse clinical events in patients with hypertrophic cardiomyopathy: a CMR study.
    Tian D; Zhang J; He Y; Xiong Z; Zhao M; Hu S; Song Q; Li Z
    BMC Cardiovasc Disord; 2023 Jan; 23(1):42. PubMed ID: 36690952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
    J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.
    Hinojar R; Zamorano JL; Fernández-Méndez M; Esteban A; Plaza-Martin M; González-Gómez A; Carbonell A; Rincón LM; Nácher JJJ; Fernández-Golfín C
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1055-1065. PubMed ID: 30706353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy".
    Tondi L; Pica S; Crimi G; Disabato G; Figliozzi S; Camporeale A; Bernardini A; Tassetti L; Milani V; Piepoli MF; Lombardi M
    Int J Cardiol; 2024 Aug; 408():132135. PubMed ID: 38705206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular and atrial functions in hypertrophic cardiomyopathy patients with very high LVOT gradient: a speckle tracking echocardiographic study.
    Tigen K; Sunbul M; Karaahmet T; Dundar C; Ozben B; Guler A; Cincin A; Bulut M; Sari I; Basaran Y
    Echocardiography; 2014 Aug; 31(7):833-41. PubMed ID: 24341920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of left atrial function in patients with hypertrophic cardiomyopathy using two-dimensional strain: a comparison with volume-derived values.
    Huang J; Yan ZN; Rui YF; Fan L; Shen D; Chen DL
    Minerva Cardioangiol; 2018 Feb; 66(1):26-37. PubMed ID: 28752727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy.
    Chung H; Kim Y; Park CH; Kim IS; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
    Cardiovasc Ultrasound; 2021 Jan; 19(1):4. PubMed ID: 33407484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
    Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
    Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
    Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Heart Failure With Preserved Left Ventricular Ejection Fraction and Impaired Left Atrial Phasic Function in Hypertrophic Cardiomyopathy: Evaluation by Cardiac MRI Feature Tracking.
    Shi R; Shi K; Huang S; Li X; Xia CC; Li Y; He S; Li ZL; He Y; Guo YK; Yang ZG
    J Magn Reson Imaging; 2022 Jul; 56(1):248-259. PubMed ID: 34799953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial and left ventricular strain in feature-tracking cardiac magnetic resonance for predicting patients at high risk of sudden cardiac death in hypertrophic cardiomyopathy.
    Zhu X; Shi Y; Lian J; Shen H; Li L; Wu H; Tian Y; Liu P
    Quant Imaging Med Surg; 2024 May; 14(5):3544-3556. PubMed ID: 38720852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Atrial Myopathy is Associated With Exercise Incapacity and Ventilatory Inefficiency in Hypertrophic Cardiomyopathy.
    Zegkos T; Kamperidis V; Ntelios D; Gossios T; Parcharidou D; Tziomalos G; Papanastasiou CA; Boutou AΚ; Katranas S; Rouskas P; Karamitsos T; Giannakoulas G; Karvounis H; Efthimiadis G
    Heart Lung Circ; 2023 Feb; 32(2):215-223. PubMed ID: 36404220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy.
    Sachdev V; Shizukuda Y; Brenneman CL; Birdsall CW; Waclawiw MA; Arai AE; Mohiddin SA; Tripodi D; Fananapazir L; Plehn JF
    Am Heart J; 2005 Apr; 149(4):730-6. PubMed ID: 15990760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial dysfunction may precede left atrial enlargement and abnormal left ventricular longitudinal function: a cardiac MR feature tracking study.
    Zhou D; Yang W; Yang Y; Yin G; Li S; Zhuang B; Xu J; He J; Wu W; Jiang Y; Sun X; Wang Y; Sirajuddin A; Zhao S; Lu M
    BMC Cardiovasc Disord; 2022 Mar; 22(1):99. PubMed ID: 35282817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.